NEWS IN BRIEF: Hill & Knowlton selected by Sankyo Pharma

NEW YORK: Hill & Knowlton's New York healthcare practice has been selected by Sankyo Pharma to represent its GlucoWatch brand - an automatic, noninvasive glucose-monitoring system that is worn like a wristwatch. The brand joins two other Sankyo products already on H&K's roster: WelChol, a cholesterol-lowering medication, and Benicar, the company's hypertension treatment.

NEW YORK: Hill & Knowlton's New York healthcare practice has been selected by Sankyo Pharma to represent its GlucoWatch brand - an automatic, noninvasive glucose-monitoring system that is worn like a wristwatch. The brand joins two other Sankyo products already on H&K's roster: WelChol, a cholesterol-lowering medication, and Benicar, the company's hypertension treatment.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.